DE60124144D1 - Pharmazeutische zusammenstellungen zur verstärkung der artzneimitteleffekte - Google Patents

Pharmazeutische zusammenstellungen zur verstärkung der artzneimitteleffekte

Info

Publication number
DE60124144D1
DE60124144D1 DE60124144T DE60124144T DE60124144D1 DE 60124144 D1 DE60124144 D1 DE 60124144D1 DE 60124144 T DE60124144 T DE 60124144T DE 60124144 T DE60124144 T DE 60124144T DE 60124144 D1 DE60124144 D1 DE 60124144D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
reinforcing
medicinal effects
drug
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60124144T
Other languages
English (en)
Other versions
DE60124144T2 (de
Inventor
Sergey Serdyuk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gevys Pharmaceuticals Ltd
Original Assignee
Gevys Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gevys Pharmaceuticals Ltd filed Critical Gevys Pharmaceuticals Ltd
Publication of DE60124144D1 publication Critical patent/DE60124144D1/de
Application granted granted Critical
Publication of DE60124144T2 publication Critical patent/DE60124144T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60124144T 2001-02-05 2001-12-19 Pharmazeutische zusammenstellungen zur verstärkung der artzneimitteleffekte Expired - Lifetime DE60124144T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/775,794 US6833377B2 (en) 2001-02-05 2001-02-05 Composition and method for potentiating drugs
US775794 2001-02-05
PCT/IB2001/002566 WO2002062388A1 (en) 2001-02-05 2001-12-19 Composition and method for potentiating drugs

Publications (2)

Publication Number Publication Date
DE60124144D1 true DE60124144D1 (de) 2006-12-07
DE60124144T2 DE60124144T2 (de) 2007-09-06

Family

ID=25105521

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60124144T Expired - Lifetime DE60124144T2 (de) 2001-02-05 2001-12-19 Pharmazeutische zusammenstellungen zur verstärkung der artzneimitteleffekte

Country Status (11)

Country Link
US (1) US6833377B2 (de)
EP (1) EP1359939B1 (de)
AT (1) ATE343399T1 (de)
AU (1) AU2002219417B2 (de)
CA (1) CA2437351A1 (de)
DE (1) DE60124144T2 (de)
DK (1) DK1359939T3 (de)
ES (1) ES2275624T3 (de)
IL (2) IL157226A0 (de)
PT (1) PT1359939E (de)
WO (1) WO2002062388A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192220A1 (en) * 2001-02-05 2005-09-01 Gevys Pharmaceuticas Ltd. Composition and method for potentiating drugs
WO2013059629A1 (en) 2011-10-21 2013-04-25 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
US9877921B2 (en) 2005-09-09 2018-01-30 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
US20160045457A1 (en) 2005-09-09 2016-02-18 Ousama Rachid Epinephrine fine particles and methods for use thereof for treatment of conditions responsive to epinephrine
TW200800142A (en) * 2005-09-09 2008-01-01 Univ Manitoba Fast-disintegrating epinephrine tablets for buccal or sublingual administration
WO2007143675A2 (en) * 2006-06-05 2007-12-13 Verus Pharmaceuticals, Inc. Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies
WO2007143676A2 (en) * 2006-06-05 2007-12-13 Verus Pharmaceuticals, Inc. Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
US20080108970A1 (en) * 2006-11-08 2008-05-08 Viertio-Oja Hanna E Control of Drug Administration
CA2716080C (en) * 2008-02-20 2016-12-13 Targia Pharmaceuticals Cns pharmaceutical compositions and methods of use
US8729070B2 (en) * 2008-02-20 2014-05-20 Targia Pharmaceuticals CNS pharmaceutical compositions and methods of use
US20120322884A1 (en) 2010-03-01 2012-12-20 University Of Manitoba Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
CA3169368A1 (en) 2012-06-15 2014-01-09 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
DK2976072T3 (da) 2013-03-22 2021-08-16 Univ Nova Southeastern Epinephrinfinpartikler og fremgangsmåder til anvendelse deraf til behandling af tilstande, der reagerer på epinephrin
WO2016027259A1 (en) * 2014-08-21 2016-02-25 Targia Pharmaceuticals Cns pharmaceutical compositions and methods of use
US20190343780A1 (en) * 2016-12-22 2019-11-14 Rvx Therapeutics Ltd. Low dose drug combinations for use in preventing and treating neuronal damage
US20220347122A1 (en) * 2019-03-15 2022-11-03 Ftf Pharma Private Limited Solutions for oral dosage

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947579A (en) 1974-06-03 1976-03-30 Nelson Research & Development Company Method and composition for potentiating neuroleptic drugs
DE3321969A1 (de) 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4843071A (en) 1986-12-05 1989-06-27 Serotonin Industries Of Charleston Method and composition for treating obesity, drug abuse, and narcolepsy
US4788189A (en) 1988-02-29 1988-11-29 Glazer Howard I Method to treat smoking withdrawal symptoms by potentiated central noradrenergic blocking
US5431922A (en) 1991-03-05 1995-07-11 Bristol-Myers Squibb Company Method for administration of buspirone
US5891842A (en) 1993-04-09 1999-04-06 Trustees Of Tufts College Methodology for eliciting an analgesic response in a living subject
CA2134038C (en) 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
FR2725623A1 (fr) 1994-10-18 1996-04-19 Flamel Tech Sa Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
EP0714663A3 (de) 1994-11-28 1997-01-15 Lilly Co Eli Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
EP0778768B1 (de) 1995-06-09 2004-05-26 Euroceltique S.A. Formulierungen und verfahren für eine verlängerte lokalanästhesie
AU1481701A (en) * 1999-11-12 2001-06-06 Neurogen Corporation Bicyclic and tricyclic heteroaromatic compounds

Also Published As

Publication number Publication date
US20030004134A1 (en) 2003-01-02
CA2437351A1 (en) 2002-08-15
DK1359939T3 (da) 2007-02-26
PT1359939E (pt) 2007-02-28
ATE343399T1 (de) 2006-11-15
EP1359939B1 (de) 2006-10-25
WO2002062388A1 (en) 2002-08-15
US6833377B2 (en) 2004-12-21
IL157226A0 (en) 2004-02-19
AU2002219417B2 (en) 2007-03-22
ES2275624T3 (es) 2007-06-16
EP1359939A1 (de) 2003-11-12
IL157226A (en) 2010-11-30
DE60124144T2 (de) 2007-09-06

Similar Documents

Publication Publication Date Title
DE60124144D1 (de) Pharmazeutische zusammenstellungen zur verstärkung der artzneimitteleffekte
SE0100568D0 (sv) Compounds
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
MXPA02002249A (es) Composiciones farmaceuticas agradables al paladar para animales de compania.
EA200700362A1 (ru) Конъюгат, содержащий антивирусное соединение, в частности ингибирующее вич, фармацевтическая композиция и набор стандартной дозы лекарственного препарата на его основе, способ ингибирования с его помощью
HK1096034A1 (en) A solid dosage form comprising a fibrate
HK1076605A1 (en) Formulations
TNSN08140A1 (de)
MXPA03008756A (es) Derivados de n-(arilsulfonil) beta-aminoacidos que comprenden un grupo aminometilo substituido, el metodo de preparacion de los mismos y las composiciones farmaceuticas que los contienen.
PT1119543E (pt) N-aralquilaminotetralinas como ligandos para o receptor y5 do neuropeptido y
FI962735A0 (fi) 2-hydroksi-5-fenylatsobensoehapon johdannaisten käyttö paksusuolen syövän kemialliseen ehkäisyyn ja kemoterapeuttisena aineena
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
AR032293A1 (es) Estuche farmaceutico
WO2001082897A3 (en) Liposome drug delivery
SG158863A1 (en) Intravenous formulations of pde-5 inhibitors
GB0222514D0 (en) Organic compounds
SE0100566D0 (sv) Compounds
SE0102440D0 (sv) New compound
WO2007011958A3 (en) Intraoral dosage forms of glucagon
PL377683A1 (pl) System terapeutyczny zawierający amoksycylinę i kwas klawulanowy
SE0101692D0 (sv) Compounds
ATE389402T1 (de) Sedierende nicht-benzodiazepin-formulierungen
SE0203817D0 (sv) New composition
WO2003105811A3 (en) PROGRESSIVE RELEASE COMPOSITIONS AND METHOD OF USE

Legal Events

Date Code Title Description
8364 No opposition during term of opposition